Botanical species · safety record

Kaempferia galanga

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Kaempferia galanga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Kaempferia galanga L.

5Constituent measurements

1Safety records

5Cited sources

9Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 9 licensed products naming Kaempferia galanga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Rhizome
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Roots and other underground parts used as staple food	Essential oil	≥ 0.19 Percent	GC-MS	Resolve DOI
1,8-cineole	Roots and other underground parts used as staple food	Essential oil	≤ 5.17 Percent	GC-MS	Resolve DOI
Estragole	Unspecified	Essential oil	61.53 Percent	Unspecified	Resolve DOI
1,8-cineole	Roots and other underground parts	Essential oil	2.4 Percent	GC-MS	No resolvable identifier
Alkaloids	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Immunotoxicity	Cardiovascular / haematological: lymph nodes	Roots and other underground parts	Solvent extraction	Rat (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Rajendra, C.E., Magadum, G.S., Nadaf, M.A., Yashoda, S.V., Manjula, M. Phytochemical screening of the rhizome of Kaempferia galanga. International journal of pharmacognosy and phytochemical research, 2011, vol. 3, no. 3, p. 61-63.
Jirovetz, L., Buchbauer, G., Shafi, P.M., Abraham, G.T. Analysis of the essential oil of the roots of the medicinal plant Kaempferia galanga L. (Zingiberaceae) from South-India. Acta pharmaceutica turcica, 2001, vol. 43, no. 2, p. 107-110.
Kanjanapothi, D., Panthong, A., Lertprasertsuke, N., Taesotikul, T., Rujjanawate, C., Kaewpinit, D., Sudthayakorn, R., Choochote, W., Chaithong, U., Jitpakdi, A., Pitasawat, B. Toxicity of crude rhizome extract of Kaempferia galanga L. (Proh Hom). Journal of ethnopharmacology, 2004, vol. 90, no. 2-3, p. 359-365. DOI
Luo, J., Wu, D., Zhong, Y.-K. Analysis of volatile components of kaempferia galanga L. from guizhou by solid phase microextraction and gas chromatography-mass spectrometry. Modern food science and technology, 2014, vol. 30, no. 12, p. 271-276. DOI
Raina, Archana P., Abraham, Z., Sivaraj, N. Diversity analysis of Kaempferia galanga L. germplasm from South India using DIVA-GIS approach. INDUSTRIAL CROPS AND PRODUCTS, 2015, vol. 69, p. 433-439. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature